Skip to main content
The NCI Community Hub will be retiring in spring 2024. For more information please visit the NCIHub Retirement Page https://ncihub.cancer.gov/groups/ncihubshutdown/timeline
close

Tags: breast cancer

More tags

All Categories (1-20 of 22)

  1. Anna Ehinger

    https://ncihub.cancer.gov/members/11920

  2. Princess Ekpo

    https://ncihub.cancer.gov/members/7915

  3. RONG ZHOU

    https://www.med.upenn.edu/apps/faculty/index.php/g334/p4498

    https://ncihub.cancer.gov/members/4174

  4. Clinical Research Program Manager, School of Medicine,Johns Hopkins University, Baltimore, MD

    Collections | 16 Aug 2017 | Posted by Julia Faith Houston

    https://ncihub.cancer.gov/groups/gmap/collections/job-postings

  5. Integrative Cancer Biology Program Datasets

    out of 5 stars 

    26 Apr 2016 | | Contributor(s):: Jonathan Bistline, Michael Reich

    The NCI-ICBP promotes an integrative/systems approach to the study of cancer biology. The Program encourages scientists to study cancer as a complex biological system. Information gained from these studies are used to build reliable and testable predictive computation models of cancer processes...

  6. Daniele Marie Gilkes

    https://ncihub.cancer.gov/members/3048

  7. Breast Cancer Crossword

    out of 5 stars 

    20 Nov 2015 | | Contributor(s):: Katelyn Schifano

    This crossword is designed for use in social media as well as patient waiting areas.

  8. Anant Madabhushi

    Dr. Anant Madabhushi is the Director of the Center for Computational Imaging and Personalized Diagnostics (CCIPD) and a Professor in the Departments of Biomedical Engineering, Pathology, Radiology,...

    https://ncihub.cancer.gov/members/2676

  9. Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment

    out of 5 stars 

    18 Aug 2015 | | Contributor(s):: Odemaris Narvaez del Pilar

    Breast cancer is one of the leading causes of cancer related deaths and morbidity among women worldwide. Identifying new targets and developing new therapies is very important in order to improve patient outcomes and minimize this health burden. MicroRNAs, a type of non-coding RNA, are potential...

  10. David C Newitt

    https://ncihub.cancer.gov/members/2208

  11. Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment

    Collections | 07 Apr 2015 | Posted by Sunita LaShawn Hamilton

    https://ncihub.cancer.gov/groups/mdphdprogram/collections/poster-presentations

  12. Mike Wendt

    https://ncihub.cancer.gov/members/2124

  13. Gennifer Goode

    https://ncihub.cancer.gov/members/1980

  14. LBL ICBP50 integrative genomic data

    out of 5 stars 

    13 Nov 2014 | | Contributor(s):: Joe Gray, Jonathan Bistline

    From Joe Gray, Lawrence Berkeley National Laboratory.  There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...

  15. Baylor Residual breast cancer

    out of 5 stars 

    13 Nov 2014 | | Contributor(s):: Creighton C, Lewis M, Chang J, Jonathan Bistline

    Residual breast cancers after conventional therapy display mesenchymal as tumor-initiating features.  There are four (4) files included in this study: Sample Annotation (combined_sample_annotation.txt) Gene expression data from CD44+/CD24- cells sorted by flow cytometry (GSE7513.gct) Human...

  16. Rita Nahta

    https://ncihub.cancer.gov/members/1772

  17. Deeonna

    https://ncihub.cancer.gov/members/1754

  18. Integrated analysis of breast cancer cell lines reveals unique signaling pathways

    out of 5 stars 

    16 Sep 2014 | | Contributor(s):: Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman

    AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...

  19. Jonathan Michael Irish

    Irish LabVanderbilt UniversityA central goal of our research at Vanderbilt is to understand how changes at the single cell level alter signaling in healthy cells and lead to therapy resistant...

    https://ncihub.cancer.gov/members/1568

  20. Kent Hunter

    https://ncihub.cancer.gov/members/1464